Jul 7, 2008 - possibly breast cancers4,5. However, in most advanced tumors, the response to antian- giogenic therapy, even in combination with conventional chemotherapy6, is not long lasting, and tumor cells bypass targeted sig- naling pathways and r
Oct 20, 2008 - Co-author Santo Fortunato of the Institute for Scientific Interchange in Turin, Italy, says that they ... Filing system: cross-discipline research.
